Upgrade to SI Premium - Free Trial

Insys Therapeutics (INSY) Releases Statement Addressing New York Attorney General’s Complaint

February 2, 2018 5:47 AM
INSYS Therapeutics, Inc. (NASDAQ: INSY) today released the following statement in response to a complaint filed by the New York ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Litigation Management Comments

Next Articles